US drug imports
Indian Generic Medicines Unaffected by Trump's 100% Pharmaceutical Import Tariff
Sep 26, 2025 05:57 pm CST
President Trump's new 100% tariff on pharmaceutical imports targets only patented and branded products, leaving Indian generic medicines unaffected according to the Indian Pharmaceutical Alliance. With Indian companies supplying 47% of US pharmaceutical needs and generating $219 billion in healthcare savings in 2022 alone, industry leaders remain confident in their market position as they continue providing affordable medications to American consumers.
Trump Announces 100% Tariff on Pharmaceutical Imports Unless Companies Build US Manufacturing Plants
Sep 26, 2025 11:42 am CST
President Donald Trump has announced 100% tariffs on pharmaceutical imports effective October 1, 2025, with exemptions for companies actively constructing manufacturing facilities in the US. The policy could significantly impact India's pharmaceutical sector, which exports over $3.6 billion in products to the US annually. This move follows recent 50% tariffs imposed on India for purchasing Russian oil, as bilateral trade negotiations continue.